The ZOLL Foundation

Early-stage research funding

ZOLL Foundation Board of Directors

The ZOLL Foundation is a 501 (c)(3) nonprofit organization governed by a Board of Directors, separate and distinct from ZOLL Medical Corporation. The Board has the responsibility of reviewing applications to identify those that are within the scope and intent of the Foundation's mission, and of determining the level of support for such projects.

The Board is comprised of current and former employees of ZOLL Medical who serve on a volunteer basis, as well as independent directors.

Ward M. Hamilton, President, ZOLL Foundation
Elected president of the ZOLL Foundation in 2018, Mr. Hamilton joined ZOLL Medical as vice president of marketing in 1992 and retired from his role of senior vice president in 2017. Prior to ZOLL, Mr. Hamilton was employed by the City of Pasadena Fire Department, Datascope Corp., and Laerdal Medical. He has worked in the field of resuscitation and devices for more than 40 years. Mr. Hamilton received a BA in political science from Hartwick College and holds a master's degree in public administration from the University of Southern California. He has served on the Board of Directors for the Citizen CPR Foundation and Sudden Cardiac Arrest Foundation, and has been active in the American Heart Association.

Richard A. Packer, Secretary
Mr. Packer is the Primary Group Executive for Asahi Kasai Health Care. He joined ZOLL Medical in 1992, became president of the company in 1996, and currently serves as its chairman. Mr. Packer holds an MBA from the Harvard Business School and engineering degrees from Rensselaer Polytechnic Institute. A former board member of MassMedic, he serves on boards of directors for a number of public and private companies, as well as nonprofit organizations.

John P. Bergeron, Treasurer
Mr. Bergeron joined ZOLL Medical in 2000, retiring as the company's vice president and corporate treasurer in 2021. Previously, Mr. Bergeron served as vice president at Ionics, Inc., a global separations technology company, where he also had the roles of corporate treasurer and tax director. Mr. Bergeron has also served in a variety of tax-related positions at other multinational corporations. He has a BA in business administration from the University of Massachusetts at Amherst and a master's degree in taxation from Bentley University.

Gary A. Freeman
Mr. Freeman joined ZOLL in 1989. Over the course of more than three decades, he held a variety of positions, including vice president of Clinical Affairs, vice president of Technology, and vice president of Intellectual Property, until his retirement in 2024. Additionally, he collaborated with Dr. Paul Zoll in research on electrodes and pacing electrophysiology in the early years of the company. Mr. Freeman holds a Master's degree in electrical engineering from Boston University and a BA from Bennington College. Mr. Freeman is the inventor of over 385 granted U.S. patents.

Fumito Ichinose, MD, PhD
Dr. Ichinose is the William Thomas Green Morton Professor of Anaesthesia at Harvard Medical School and a cardiothoracic anesthesiologist at Massachusetts General Hospital. A physician-scientist who is actively involved in patient care, basic and translational science research, and drug development, Dr. Ichinose's research focus includes mechanisms of hypoxic ischemic brain injury, neurodegeneration, and artificial hibernation. His research has been continuously funded by grants from National Institute of Health and National Science Foundation in the past 18 years.

Coreen M. Packer
Mrs. Packer is a former principal of the Garvey Group, Inc., a real estate investment company, and served as a vice president in the real estate asset management department of the Bank of New England. Mrs. Packer, who has a BA in history from the University of New Hampshire, is active in many local voluntary community organizations. She is also a trustee of the Packer Family Charitable Trust.

Norman A. Paradis, MD
Dr. Paradis is a professor of medicine at Dartmouth College and an emergency physician at Dartmouth Hitchcock Medical Center. He is active in biomedical research and medical device development. His research interests include cardiac arrest and shock, as well as molecular and optical biomarkers. He currently leads a Department of Defense-funded collaboration developing innovative diagnostics in trauma, and is founder/CEO of CPR Therapeutics, Inc., which is developing next-generation therapy for cardiac arrest. Dr. Paradis has been chief medical officer for a number of companies, and he edits the leading textbook in resuscitation medicine. Dr. Paradis has been chief of emergency medicine at Dartmouth and medical director at the University of Colorado, and has been on faculty at NYU, Columbia, USC, and VCU.

Jonathan A. Rennert
Mr. Rennert was named chief executive officer of ZOLL in April 2016 after having served as president of the company's Resuscitation division since 2008. Prior to joining ZOLL, Mr. Rennert led the analytical instruments business at PerkinElmer, Inc., and held leadership positions in manufacturing and engineering at United Technologies (now Carrier Corp.) and General Electric. Mr. Rennert holds an MS in management studies from the MIT Sloan School of Management, an MS in mechanical engineering from the Massachusetts Institute of Technology (MIT), and a BS in mechanical and aerospace engineering from Princeton University.